Cargando…

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

BACKGROUND: (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) has been used extensively to explore whether FDG Uptake can be used to provide prognostic information for esophageal cancer patients. The aim of the present review is to evaluate the literature available to date concerning t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Gastrointestinal Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192273/ https://www.ncbi.nlm.nih.gov/pubmed/21537872 http://dx.doi.org/10.1245/s10434-011-1732-1

Ejemplares similares

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
por: Schreurs, L. M. A., et al.
Publicado: (2011)

A High Body Mass Index in Esophageal Cancer Patients Does Not Influence Postoperative Outcome or Long-Term Survival
por: Blom, R. L. G. M., et al.
Publicado: (2011)

Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
por: Anderegg, M. C. J., et al.
Publicado: (2017)

Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer
por: Nederlof, Nina, et al.
Publicado: (2016)

A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit
por: van der Werf, L. R., et al.
Publicado: (2018)

NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial)
por: van Heijl, Mark, et al.
Publicado: (2008)

Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands
por: Gertsen, Emma C., et al.
Publicado: (2020)

Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study
por: Borgstein, Alexander B. J., et al.
Publicado: (2021)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

Outcome of Patients Treated Within and Outside a Randomized Clinical Trial on Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: Extrapolation of a Randomized Clinical Trial (CROSS)
por: Toxopeus, Eelke, et al.
Publicado: (2018)

Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer
por: Beukinga, Roelof J., et al.
Publicado: (2020)

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study
por: Voeten, Daan M., et al.
Publicado: (2021)

Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer
por: Faiz, Zohra, et al.
Publicado: (2018)

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer
por: van der Werf, Leonie R., et al.
Publicado: (2019)

Cervical ultrasonography has no additional value over negative (18)F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer
por: Goense, Lucas, et al.
Publicado: (2017)

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
por: van de Schoot, L., et al.
Publicado: (2007)

Gastric cancer and image-derived quantitative parameters: Part 2—a critical review of DCE-MRI and (18)F-FDG PET/CT findings
por: Tang, Lei, et al.
Publicado: (2019)

A Critical Appraisal of Circumferential Resection Margins in Esophageal Carcinoma
por: Pultrum, Bareld B., et al.
Publicado: (2009)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023)

Routinely staging gastric cancer with (18)F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
por: Findlay, John M., et al.
Publicado: (2019)

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review
por: Wang, H. H., et al.
Publicado: (2023)

Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers
por: Black, Douglas, et al.
Publicado: (2017)

Utility of [(68)Ga]FAPI-04 and [(18)F]FDG dual-tracer PET/CT in the initial evaluation of gastric cancer
por: Miao, Ying, et al.
Publicado: (2022)

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer
por: de Heer, E. C., et al.
Publicado: (2017)

Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival
por: Pultrum, B. B., et al.
Publicado: (2010)

Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer
por: Gottlieb-Vedi, Eivind, et al.
Publicado: (2018)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Surgery for Esophageal Cancer: Quality of Life Matters
por: Salo, Jonathan C
Publicado: (2009)

Better Survival in Patients with Esophageal Cancer After Surgical Treatment in University Hospitals: A Plea for Performance by Surgical Oncologists
por: Verhoef, Christian, et al.
Publicado: (2007)

Unique case of esophageal rupture after a fall from height
por: van Heijl, Mark, et al.
Publicado: (2009)

Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
por: Runge, Jurgen H., et al.
Publicado: (2020)

Viable Tumor Tissue Adherent to Needle Applicators after Local Ablation: A Risk Factor for Local Tumor Progression
por: Snoeren, Nikol, et al.
Publicado: (2011)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
por: David, John M., et al.
Publicado: (2019)

Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study
por: van de Graaf, F. W., et al.
Publicado: (2016)

Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
por: van Iersel, Liselot B. J., et al.
Publicado: (2008)

Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)

Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off
por: Luboldt, Wolfgang, et al.
Publicado: (2010)

Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
por: Ma, Lucy X, et al.
Publicado: (2022)

Diagnostic Laparoscopy as a Selection Tool for Patients with Colorectal Peritoneal Metastases to Prevent a Non-therapeutic Laparotomy During Cytoreductive Surgery
por: Hentzen, Judith E. K. R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3p2v3mguapu93khg0c2ifon84e